Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 4 de 4
Filtrer
Plus de filtres











Base de données
Gamme d'année
1.
J Drugs Dermatol ; 23(9): 790-791, 2024 09 01.
Article de Anglais | MEDLINE | ID: mdl-39231073

RÉSUMÉ

Platelet-rich concentrates (PRCs), derived from a patient's blood, are being used in various fields of medicine, including dermatology, for an increasing number of indications. Although considered a generally safe procedure for dermatologic indications, there have been reports in the last several years linking this treatment to cases of blood-borne infections including HIV and hepatitis.1 Patient safety should always be the primary focus for physicians and other health care professionals, and systems-based protocols should exist within care settings to minimize errors. Herein, we review our protocol to decrease the risk of complications related to transmission of blood-borne infections and other medical errors related to PRCs. J Drugs Dermatol. 2024;23(9)790-791. doi:10.36849/JDD.8166.


Sujet(s)
Erreurs médicales , Plasma riche en plaquettes , Humains , Pathogènes transmissibles par le sang , Protocoles cliniques , Dermatologie/méthodes , Dermatologie/normes , Erreurs médicales/prévention et contrôle , Sécurité des patients/normes , Maladies de la peau/thérapie
2.
Dermatol Surg ; 50(8): 695-698, 2024 Aug 01.
Article de Anglais | MEDLINE | ID: mdl-38595132

RÉSUMÉ

BACKGROUND: Desmoplastic trichoepithelioma (DTE) is an uncommon benign adnexal tumor that histologically may mimic malignant tumors including basal cell carcinoma and microcystic adnexal carcinoma. OBJECTIVE: To present a systematic review of the epidemiology, clinical characteristics, treatment, and outcome data on DTEs, with emphasis on comparing Mohs micrographic surgery (MMS) with other treatments. METHODS: Using the OVID platform, MEDLINE and Embase were searched from inception for studies providing original data on DTEs. RESULTS: A total of 338 cases of DTE from 61 articles were included. No recurrence/persistence (0%) was reported following MMS ( n = 24, mean follow-up of 41.9 months), 13.1% with standard excision ( n = 38, mean follow-up 16.9 months), and 2.1% for electrosurgery/cautery ( n = 49, follow-up 3-72 months). 100% recurrence/persistence for imiquimod ( n = 2) and liquid nitrogen ( n = 4) were identified. In patients who underwent biopsy only, there was a 12.5% recurrence/persistence ( n = 32, mean follow-up 16.5 months). Overall, duration of follow-up varied from 2 months to 6 years for the various management strategies. CONCLUSION: Data are limited regarding DTE outcomes. In this review, surgical modalities, specifically MMS, had the lowest rates of recurrence/persistence compared with other options. Given that most lesions are found on cosmetically sensitive locations, MMS seems to be the optimal management strategy for actively managing DTEs.


Sujet(s)
Chirurgie de Mohs , Tumeurs cutanées , Humains , Chirurgie de Mohs/statistiques et données numériques , Tumeurs cutanées/chirurgie , Tumeurs cutanées/anatomopathologie , Tumeurs cutanées/épidémiologie , Résultat thérapeutique , Récidive tumorale locale/épidémiologie , Récidive tumorale locale/anatomopathologie , Imiquimod/usage thérapeutique , Imiquimod/administration et posologie , Tumeurs des annexes cutanées/anatomopathologie , Tumeurs des annexes cutanées/chirurgie , Tumeurs des annexes cutanées/épidémiologie , Électrochirurgie/méthodes
3.
J Cosmet Dermatol ; 23(6): 1936-1939, 2024 Jun.
Article de Anglais | MEDLINE | ID: mdl-38572518

RÉSUMÉ

BACKGROUND: Keratoacanthomas (KAs) following laser treatment are a rare, but well-described entity. AIM: Herein, we describe a case of eruptive keratoacanthoma (KA) following laser resurfacing treatment and aim to better characterize laser-associated KAs. METHODS: A literature search was performed on PubMed reviewing laser-associated KAs including various characteristics: epidemiology, history of skin cancer, location, and number, type of laser, as well as the management and outcome. RESULTS: Fractional ablative was the most common type of laser triggering KAs, and most cases presented within the first month following treatment. The majority of cases of laser-induced KA had a prior history of a malignant or premalignant skin neoplasm. Laser-induced KAs were treated using modalities similar to KAs arising in other contexts. CONCLUSION: Clinicians need to be knowledgeable and prepared to understand, and manage complications following laser treatments, as rare as they may be, including KAs.


Sujet(s)
Kératoacanthome , Thérapie laser , Rémission spontanée , Humains , Kératoacanthome/étiologie , Kératoacanthome/chirurgie , Kératoacanthome/anatomopathologie , Kératoacanthome/diagnostic , Thérapie laser/effets indésirables , Femelle , Tumeurs cutanées/étiologie , Tumeurs cutanées/anatomopathologie , Tumeurs cutanées/chirurgie , Tumeurs cutanées/diagnostic , Adulte d'âge moyen
4.
SAGE Open Med Case Rep ; 11: 2050313X231193075, 2023.
Article de Anglais | MEDLINE | ID: mdl-37581113

RÉSUMÉ

A 67-year-old female was treated for a left nasal ala basal cell carcinoma; post-Mohs defect was 1.5 × 1.5 cm and extended to involve the perialar cheek and apical triangle of the upper lip. How would you repair this defect?

SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE